7-[[2,3,4,5-TETRAHYDRO-2-(4-METHOXYPHENYL)-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE
Compound with spectra: 1 NMR
![7-[[2,3,4,5-TETRAHYDRO-2-(4-METHOXYPHENYL)-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE](/api/compound/1bPAiwBVo3b.png?ph=true&h=300&w=458 "7-[[2,3,4,5-TETRAHYDRO-2-(4-METHOXYPHENYL)-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE")
| SpectraBase Compound ID | 1bPAiwBVo3b |
|---|---|
| InChI | InChI=1S/C22H19NO5/c1-14-12-22(28-21(14)25,16-5-8-17(26-2)9-6-16)13-27-18-7-3-15-4-10-20(24)23-19(15)11-18/h3-11H,1,12-13H2,2H3,(H,23,24) |
| InChIKey | YJYYWMYYTSASGX-UHFFFAOYSA-N |
| Mol Weight | 377.4 g/mol |
| Molecular Formula | C22H19NO5 |
| Exact Mass | 377.126323 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
7-[[2-(4-BROMOPHENYL)-2,3,4,5-TETRAHYDRO-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE
7-[[2-(4-FLUOROPHENYL)-2,3,4,5-TETRAHYDRO-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE
7-[[2-(4-CHLOROPHENYL)-2,3,4,5-TETRAHYDRO-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY]-QUINOLIN-2(1H)-ONE
7-{[2,3,4,5-TETRAHYDRO-2-(4-METHOXYPHENYL)-4-METHYLENE-5-OXO-2-FURANYL]-METHOXY}-2-H-1-BENZOPYRAN-2-ONE
7-{[2,3,4,5-TETRAHYDRO-4-METHYLENE-5-OXO-2-(4-PHENYLPHENYL)-2-FURANYL]-METHOXY}-2-H-1-BENZOPYRAN-2-ONE
7-[(2,3,4,5-TETRAHYDRO-4-METHYLENE-5-OXO-2-PHENYL-2-FURANYL)-METHOXY]-4-METHYL-2-H-1-BENZOPYRAN-2-ONE
(R)-3-(2,2-Dimethylcyclopropyl)-2-oxo-1,2-dihydroquinolin-7-yl 4-bromobenzoate
7-HYDROXY-4-(5'-HYDROXYMETHYLFURAN-2'-YL)-2-QUINOLONE
2-furancarboxamide, N-[7-(cyclopropylhydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-
METHYL-3-(4-{1-(3,4-DIMETHOXYPHENYL)-3-HYDROXY-2-[2-METHOXY-4-(2-METHOXYCARBONYLVINYL)-PHENOXY]-PROPOXY}-PHENYL)-ACRYLATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Certain Quinolin-2(1H)-one α-Methylene-γ-butyrolactones as Potential Antiplatelet Agents | HETEROCYCLES | 1999 |